The sera of 100 Colombian individuals of African origin living in a malaria-endemic area of the Pacific coast were studied with regard to their capacity to inhibit Plasmodium falciparum cultures in vitro. Antimalarial antibody levels determined by indirect immunofluorescence were higher in the group of infected individuals than in the noninfected individuals, and inhibitory activity assessed by the inhibition of parasite incorporation of 3H-hypoxanthine in vitro was present in the sera of both the infected and noninfected patients. We believe that the noninfected patients were probably immune. The sera of some of the infected patients had high inhibitory capacities for the P. falciparum FCB-1 isolate. When the inhibitory effects of some of the sera were tested by using four parasite isolates from different regions of the world, striking differences among them were found.
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Serum transfer experiments have clearly demonstrated the importance of humoral factors in the control of malaria infections (5, 15) . Furthermore, it is known that naturally acquired antibodies play a significant role in neutralizing the extracellular parasites (6, 17) . Antibodies can also prevent the binding of infected erythrocytes to endothelial cells and may operate by inhibiting the sequestration of Plasmodium falciparum in the deep vascular system of the host (21) .
It has been observed, both in vivo and in vitro, that immune sera of humans and experimental animals may contain, in addition to antibodies, soluble mediators capable of producing inhibition and damage of intraerythrocytic parasites (9, 18) . The resulting damaged intracellular parasites have been called crisis forms (19) and can be produced by the presence of reactive oxygen radicals (1) or by crisis form factor (CFF) (9) . Although the chemical nature of CFF has not yet been elucidated, it is known to be a nondialyzable factor which is different from antibodies, tumor necrosis factor, and alpha or gamma interferon (4, 12) .
CFF seems to play an important role in acquired immunity to malaria. It was found in the sera of individuals from endemic areas of Sudan, sera which were functionally immune to malaria in the absence of high antibody titers. In contrast, CFF was not found in individuals from Indonesia, where acquired immunity to malaria was less effective and seemed to depend mainly on the presence of anti-merozoite antibodies in the population (11). Marsh et al. (14) studied a Gambian rural population with apparently the same malaria epidemiological characteristics as the population studied previously by Jensen et al. (9) in Sudan. In this study, no differences were found in the parasite growth when exposed to sera of nonimmune Europeans or immune Gambians. Butcher et (16) . Asexual blood forms of the FCB-1 Colombian isolate of P. falciparum were used as an antigen source.
INHIBITION OF P. FALCIPARUM IN VITRO CULTURES
Parasitemia. Parasitemia was determined on Giemsastained thick smears and quantified on the basis of leukocyte counts.
Parasite cultures. Four different P. falciparum isolates (FCB-1 from Colombia, T-4 from Thailand, FCR-3 from Gambia, and FUP Palo Alto from Uganda) were maintained in continuous in vitro culture, according to the method of Trager and Jensen (20) , and used for the inhibition assays.
Inhibition assays. Prior to performance of the inhibition assays, the parasites were highly synchronized to ring stages by a combination of the gelatin flotation method (8) and lysis of the mature stages with 5% sorbitol (13) .
Parasites were cultured in 96-well flat-bottomed microculture plates in complete RPMI 1640 medium without hypoxanthine and containing 10% of the test serum.
In order to remove chloroquine or other antimalarial drugs which might be in the sera and to equilibrate with the parasite culture medium, all test sera were previously dialyzed for 24 h against RPMI 1640 medium diluted 1:100 in double-distilled water supplemented with 25 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) and 0.21% sodium bicarbonate (dialysis medium). Each single serum was dialyzed against 1,000-fold its own volume.
Microcultures were set up in quadruplicate in volumes of 100 ,ul with 5% hematocrit, 3% of ring-infected erythrocytes, and medium supplemented with 10% of either test sera or normal pooled sera.
After 24 h of culture, the supernatants were removed and a fresh medium containing the same sera was added. At this time, microcultures were labeled with 3H-hypoxanthine (Dupont, NEN Research Products) dissolved in RPMI 1640 medium at a concentration of 1 ,uCi per well of culture. Sixteen hours later, microcultures were harvested onto glass fiber filters (Cambridge Technology Inc.) with a cell collector (Mini-Mash, Microbiological Associates), and the incorporation of the 3H-hypoxanthine into parasite nucleic acids was measured by using a liquid scintillation system (LS 3801; Beckman Instruments, Inc.). The assay was also evaluated qualitatively by visual examination of thin films stained with Giemsa stain.
We selected as normal parasite growth the range of values produced by 10 serum specimens previously selected because of their good capacity to support the in vitro parasite growth. The mean of these individual values was similar to the growth produced by the pool of the same sera and was considered to be 100% growth. The same pool of normal sera was used throughout the whole study.
According to the behavior of the normal sera from both the pool and the normal control group, we arbitrarily labeled activity as normal (0 to 20% inhibition), moderate (21 to 50%), and severe (51 to 100%) (Fig. 1) .
Serum fractions. Sera that showed inhibitory activity higher than 50% were precipitated with 35% (vol/vol) (NH4)2SO4 for 8 h at 4°C, and both fractions, supernatants and precipitates, were dialyzed for 36 h at 4°C. For the first 24 h, each sample was dialyzed against 1,000 times its volume with 0.02 M phosphate buffer (K2HPO4), pH 8.0, and then against RPMI 1640 culture medium at the same ratio. Dialysates were changed at 24-h intervals.
The precipitates were diluted to 5% in complete RPMI 1640 medium supplemented with 5% of the normal pool sera and tested for inhibitory activity as described above. On the other hand, the supernatants were additionally passed through a chromatography column containing Sepharose CL-4B conjugated with (Fig. 2) .
The control group showed an inhibition mean of 2.72% with a confidence interval between -2.16 and 7.60%, which was similar to the behavior presented by the individual sera of the normal pool (data not shown). The infected group showed a mean of 14.84% with a confidence interval between 6.56 and 23.12%, whereas the immune group showed a mean of 29.03% with a confidence interval between 20.13 and 37.93%. All groups presented several individuals on the negative side of inhibition (Fig. 1, dots below the zero line) , meaning that these sera could stimulate the parasite growth as well as the normal sera.
There was no statistically significant difference in the percentage of inhibition between the infected and the control groups. We found, however, a significant difference between the control group and the immune set of sera. The sera of 36% of the individuals from the infected group and 58% of the immune group were inhibitory. Of the sera from infected patients and immune subjects, 12 and 28%, respectively, produced inhibitions above 50%.
Since there was no relationship between antibody titers and inhibitions, the nonantibody fractions of the sera were tested. All sera with high inhibitory activity were fractionated both by salt precipitation and affinity chromatography. Inhibitory activity was found exclusively in the soluble fraction. Not one of the immunoglobulin G precipitates produced significant inhibition of the culture (Table 1) .
We did not find any correlation among the symptoms referred to by the patients, the number of previous malaria episodes, and the parasitemia and their inhibitory capacity in vitro (r = 0.046, P = 0.80). Interestingly, one of the individuals (011) who showed the strongest inhibition in vitro carried at the same time the highest parasitemia (152 x 103 parasites per ,ul) and an antimalarial antibody titer of 1:640. This suggested that the inhibitory activity observed in vitro, but apparently ineffective in vivo, could be strain specific. Therefore, we tested the susceptibility of several isolates of P. falciparum to the inhibitory activity of serum supernatants obtained from some of the individuals we were investigating. There were some sera (004 and 013) which were inhibitory for all isolates and others (014, 035, and 036) which inhibited only one or two isolates. Some sera (001, 008, 010, 012, 017, and 021) were inhibitory for all isolates except one (Table 2) . Thus, there appears to be isolate variation in the susceptibility to inhibition by a given serum or variability in the effects of the different sera on a single isolate.
The percentage of inhibition of these sera was again calculated according to the growth induced in each parasite strain by the pool of normal sera.
All four strains of parasites were typed by using monoclonal antibodies (kindly provided by Jana S. McBride from the University of Edinburgh, Edinburgh, Scotland) in order to see whether there was any correlation between this different susceptibility to the CFF and antigenic diversity. It was impossible, however, to determine any pattern of correlation between serotyping and inhibition.
DISCUSSION
We have found that sera from individuals of African origin living in a P. falciparum-and P. vivax-endemic area of the Colombian Pacifie coast do have inhibitory activity for parasite growth in vitro. The high prevalence (47%) of this inhibitory activity in individuals of the region and its nondialyzable nature are similar to the CFF activity described by Jensen et al. (10) in Sudan. However, we found that the inhibitory factor occurred in both infected and immune individuals. There was no apparent correlation among the inhibitory activity, frequency of previous malaria episodes, clinical symptoms, and parasitemia.
The inhibitory activity of these sera was present in the antibody-free fraction of the sera. Titers of specific anti-P. falciparum blood Immune individuals who had been followed for more than 3 months and who had not had any malarial episode presented inhibitory activity more frequently.
The difference in the prevalence of the factor in both groups was not significant. If the inhibitory factor was specifically induced by malarial parasites, the fact that these individuals did not complain of malaria or have high titers of antimalarial antibodies would suggest that their infections may have been aborted before they produced any symptoms which would induce parasitemias and increase the levels of antibodies. Alternatively, it is possible that the immune system could be stimulated by other microorganisms to induce the production of cytokines, which might stimulate mononuclear cells to produce the inhibitory factor. This could explain why the group of immune individuals maintained such high levels of CFF in the absence of circulating parasites. In this case, the infection may occur only when the individuals are in contact with parasites which are not inhibited by the factor being produced. The polymorphism of inhibition displayed by the different isolates renders this possible.
So far, almost all studies on CFF have been conducted using only one isolate of P. falciparum. It is possible that by using several isolates of the parasite, the presence of inhibition might be detected in a number of other countries of high malaria endemicity.
In summary, our results indicate that sera of infected or immune individuals contain an inhibitory factor for parasite growth in vitro. The high prevalence and nonantibody nature of this factor implies that it may be similar to CFF described previously by Jensen et al. (10) . Studies are being conducted to determine the chemical nature of CFF. In our case, the presence of the factor did not appear to correlate well with clinical immunity. A new finding was the diversity of inhibitory activity on the growth of different parasite isolates.
